Impact Partnership Wealth LLC Has $466,000 Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Impact Partnership Wealth LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 4.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 4,219 shares of the company’s stock after selling 210 shares during the period. Impact Partnership Wealth LLC’s holdings in Cardinal Health were worth $466,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CAH. Eastern Bank acquired a new stake in Cardinal Health during the third quarter worth approximately $25,000. Cultivar Capital Inc. bought a new position in shares of Cardinal Health during the second quarter worth approximately $27,000. LRI Investments LLC acquired a new stake in Cardinal Health during the 1st quarter worth approximately $32,000. Ashton Thomas Private Wealth LLC bought a new stake in Cardinal Health in the 2nd quarter valued at $29,000. Finally, Palisade Asset Management LLC acquired a new position in Cardinal Health in the 1st quarter valued at $34,000. 87.17% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of research reports. Robert W. Baird lifted their target price on Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a report on Thursday, August 15th. Citigroup cut their price objective on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a report on Friday, July 19th. Morgan Stanley increased their target price on shares of Cardinal Health from $114.00 to $119.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. Argus lifted their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, September 11th. Finally, UBS Group increased their price target on Cardinal Health from $125.00 to $134.00 and gave the stock a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $120.18.

Cardinal Health Stock Performance

Shares of Cardinal Health stock traded up $0.64 during trading on Thursday, reaching $112.56. 51,455 shares of the company’s stock were exchanged, compared to its average volume of 2,063,463. Cardinal Health, Inc. has a 1-year low of $90.19 and a 1-year high of $116.05. The company has a market cap of $27.42 billion, a P/E ratio of 49.74, a PEG ratio of 1.57 and a beta of 0.60. The firm’s 50-day moving average price is $111.54 and its 200 day moving average price is $103.99.

Cardinal Health (NYSE:CAH) last posted its earnings results on Wednesday, August 14th. The company reported $1.84 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10. The firm had revenue of $59.87 billion during the quarter, compared to analysts’ expectations of $58.74 billion. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The business’s revenue for the quarter was up 12.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.55 earnings per share. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.61 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st were paid a $0.506 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.80%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Tuesday, October 1st. Cardinal Health’s dividend payout ratio is presently 89.78%.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 46,455 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $109.02, for a total value of $5,064,524.10. Following the completion of the transaction, the chief executive officer now owns 197,636 shares of the company’s stock, valued at $21,546,276.72. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Cardinal Health news, CEO Jason M. Hollar sold 46,455 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $109.02, for a total value of $5,064,524.10. Following the completion of the transaction, the chief executive officer now directly owns 197,636 shares in the company, valued at approximately $21,546,276.72. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Aaron E. Alt sold 2,323 shares of Cardinal Health stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the transaction, the chief financial officer now owns 36,867 shares in the company, valued at approximately $4,015,184.97. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 113,963 shares of company stock valued at $12,379,980 in the last 90 days. 0.15% of the stock is owned by corporate insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.